(Alliance News) - GSK PLC and Sanofi SA on Friday reported positive results against the Omicron variant of Covid-19 from their vaccine in a placebo-controlled trial. Read More
(Alliance News) - GSK PLC on Thursday said it is investing GBP1 billion in research & development to fight infectious diseases like HIV and malaria in lower income countries over the next 10 years. Read More
(Alliance News) - FTSE Russell on Wednesday said it expects Haleon, the Consumer Healthcare arm of GSK PLC, to commence trading on the London Stock Exchange on July 18. Read More
(Alliance News) - Sanofi SA on Monday said its Covid-19 booster jab developed alongside GSK PLC delivers a stronger immune response to the Omicron variant than other jabs. Read More
(Alliance News) - The UK economy unexpectedly contracted again in April, leaving the Bank of England in a tough spot when it meets later this week. Read More
(Alliance News) - Stock prices in London were lower at midday on Friday with market focus squarely on the upcoming US consumer price index report at 1330 BST. Read More
(Alliance News) - Stock prices in London opened lower on Friday with trepidation ahead of US inflation data in the afternoon, while GSK bucked the market trend on upbeat late-stage trial results for a vaccine. Read More
(Alliance News) - Drugmaker GSK PLC on Friday said its vaccine candidate for respiratory syncytial virus, or RSV, showed positive phase three data in older adults. Read More
(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has approved its Priorix vaccine for active immunisation for the prevention of measles, mumps and rubella in individuals of 12 months of age and older. Read More
(Alliance News) - Stock prices in London are seen opening higher on Monday, following the long holiday weekend in the UK, tracking gains in Asian equity markets as Beijing further relaxed pandemic restrictions. Read More
(Alliance News) - Stocks in London ended lower on Wednesday ahead of the extra long Jubilee bank holiday weekend as investors weigh inflation and interest rates. Read More
(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon. Read More
(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon. Read More
(Alliance News) - Stocks in London ended mixed on Tuesday with oil majors helping lift the FTSE 100, while the European counterparts grappled with record inflation. Read More
GSK PLC - London-based pharmaceutical firm formerly known as GlaxoSmithKline - Notes ViiV Healthcare Ltd received marketing approval by Japan's Ministry of Health, Labour, & and Welfare for Vocabria used in combination with Rekambys and Edurant. Read More
(Alliance News) - GSK PLC on Tuesday said it has agreed to buy Affinivax Inc for up to USD3.3 billion, to gain access its "highly innovative" next-generation 24-valent pneumococcal vaccine candidate. Read More
(Alliance News) - The FTSE 100 was outperforming European peers on Tuesday morning, as blue-chip benchmarks on the continent were suffering after EU leaders agreed a partial ban on Russian oil. Read More
(Alliance News) - GSK on Tuesday said it has agreed to pay USD2.1 billion upfront, with potentially a further USD1.2 billion coming, to acquire Boston, Massachusetts-based Affinivax. Read More